<DOC>
	<DOCNO>NCT01758705</DOCNO>
	<brief_summary>The aim study obtain Venezuelan data clinical effectiveness , impact HRQoL , work productivity activity impairment patient psoriasis use adalimumab .</brief_summary>
	<brief_title>Post Marketing Observational Study Venezuelan Patients With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subjects moderate severe chronic plaque psoriasis , without psoriatic arthritis , indication adalimumab need systemic therapy failure phototherapy , systemic topical treatment Subjects receive biologic therapy last 12 week classical therapy past 4 week and/or phototherapy last 2 week . Topical therapy allow , constant dose use within 24 hour prior visit Patients previous treatment experimental drug minimum washout period five halflives Subjects must capable understand willing give write informed consent form release information comply requirement study protocol Subjects enrol treat accordance local product label approve Venezuela Subjects enrol another study treatment investigational product History viral hepatitis B infection HIV History neurologic symptom suggestive central nervous system demyelinate disease History cancer lymphoproliferative disease ( successfully treat nonmelanoma skin cancer localize carcinoma situ cervix ) Active TB infection initiate adalimumab treatment latent TB infection able complete prophylactic treatment Pregnant lactate female . Pregnancy test enter study fertile woman . Women fertile age must advise physician , use clinically accept contraceptive method ( contraceptive pill , IUDs , barrier device condom abstinence ) History congestive heart failure ( CHF ) Any another condition accord criterion participate investigator represent obstacle study conduction / subject unacceptable risk Subjects active infection include chronic localized infection infection control History sensitive latex component syringe Subjects require concomitant phototherapy systemic therapy adalimumab therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Related Health Quality Life</keyword>
	<keyword>Patient Reported Outcomes</keyword>
	<keyword>Venezuelan Patients</keyword>
</DOC>